Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Arginine
Drug ID BADD_D00162
Description An essential amino acid that is physiologically active in the L-form.
Indications and Usage Used for nutritional supplementation, also for treating dietary shortage or imbalance.
Marketing Status investigational; nutraceutical
ATC Code B05XB01
DrugBank ID DB00125
KEGG ID D02982
MeSH ID D001120
PubChem ID 6322
TTD Drug ID D0F5DO
NDC Product Code 17333-002; 51552-0698
UNII 94ZLA3W45F
Synonyms Arginine | L-Arginine | L Arginine | Arginine, L-Isomer | Arginine, L Isomer | L-Isomer Arginine | DL-Arginine Acetate, Monohydrate | DL Arginine Acetate, Monohydrate | Monohydrate DL-Arginine Acetate | Arginine Hydrochloride | Hydrochloride, Arginine
Chemical Information
Molecular Formula C6H14N4O2
CAS Registry Number 74-79-3
SMILES C(CC(C(=O)O)N)CN=C(N)N
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anaphylactic shock10.01.07.002; 24.06.02.004---
Choking22.12.03.003---
Dermatitis23.03.04.002---
Extravasation08.01.03.008---
Flushing08.01.03.025; 23.06.05.003; 24.03.01.002--
Haematuria20.02.01.006; 21.10.01.018; 24.07.01.047--
Headache17.14.01.001--
Hyperhidrosis08.01.03.028; 23.02.03.004--
Hypersensitivity10.01.03.003--
Hypoaesthesia17.02.06.023; 23.03.03.081---
Injection site reaction08.02.03.014; 12.07.03.015--
Lethargy08.01.01.008; 17.02.04.003; 19.04.04.004--
Nasal obstruction22.12.03.013---
Nausea07.01.07.001--
Necrosis08.03.03.001; 24.04.02.006---
Phlebitis superficial24.12.03.005---
Platelet count decreased13.01.04.001--
Rash23.03.13.001---
Rash macular23.03.13.003---
Sensory loss17.02.07.007---
Sickle cell anaemia01.04.02.002; 03.15.03.001---
Skin exfoliation23.03.07.003---
Skin necrosis23.03.03.011---
Surgery25.01.02.003---
Swelling08.01.03.015---
Tachycardia02.03.02.007---
Vomiting07.01.07.003--
Brain oedema12.01.10.010; 17.07.02.003--
Paraesthesia oral07.05.05.035; 17.02.06.008---
Decreased appetite08.01.09.028; 14.03.01.005--
The 1th Page    1    Total 1 Pages